Vanguard Group Inc Precipio, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.5 - $17.4 $259 - $9,013	518 Added 0.05%	1,050,618 $577,000
Q1 2022 May 13, 2022	SELL	$1.19 - $1.71 $7,456 - $10,714	-6,266 Reduced 0.59%	1,050,100 $1.42 Million
Q4 2021 Feb 14, 2022	SELL	$1.58 - $2.77 $1,926 - $3,376	-1,219 Reduced 0.12%	1,056,366 $1.67 Million
Q3 2021 Nov 12, 2021	BUY	$2.78 - $3.63 $12,598 - $16,451	4,532 Added 0.43%	1,057,585 $2.98 Million
Q2 2021 Aug 13, 2021	BUY	$1.8 - $5.25 $1.9 Million - $5.53 Million	1,053,053 New	1,053,053 $3.82 Million

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $143M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.